Related Experiment Video
Updated: Aug 9, 2025
Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
Published on: April 27, 2014
Relationship between sexual and bladder dysfunction in women consuming ketamine
Bor-En Jong1, Shang-Jen Chang1,2, Chia-Hua Li3
1Division of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan.
Background:
Although ketamine has become the second most popular recreational drug in Taiwan, there have been very few reported studies that investigated female sexual dysfunction (FSD) in ketamine abusers (KAs).
Aims:
We sought to compare the difference between street and hospital KAs and explored the risk factors for FSD and lower urinary tract symptoms (LUTS) in KAs.
Methods:
In this cross-sectional study, female KAs aged 18 years or older were invited to complete anonymous questionnaires during an educational course provided by the departments of substance control and prevention of the local government or under the instruction of medical providers at a urology clinic. Data were reported as median (IQR) and OR and analyzed with commercial statistical software.
Outcomes:
Key outcome measurements were illicit drug use history, FSD symptoms, and LUTS severity.
Results:
We included 139 women (104 street and 35 hospital KAs) with a median age of 27.08 years. FSD was reported in 76% of all the participants (street vs hospital KAs, 68% vs 97%, P < 0.001). LUTS (Interstitial Cystitis Symptom Index [ICSI] + Interstitial Cystitis Problem Index [ICPI] ≥12) was found to be a significant risk factor for FSD in KAs. More hospital KAs (71%) reported experiencing LUTS (ICSI + ICPI ≥12) than street KAs (8%, P < 0.001). Longer duration of ketamine use (≥36 months) and mild to severe psychological symptoms (5-item Brief Symptom Rating Scale [BSRS-5] ≥6) were significant risk factors for LUTS.
Clinical Implications:
Sexual problems among KAs should not be overlooked since more severe sexual dysfunction was observed in patients reporting LUTS.
Strengths And Limitations:
To our knowledge, the present study is the largest study using validated and reliable questionnaires to examine FSD in KAs and also the first study to include street KAs. The main limitation of this study is using self-report questionnaires as they are subjective and susceptible to human errors and recall biases.
Conclusions:
Women who abused ketamine and reported experiencing LUTS were found to be more likely to have FSD.
Related Concept Videos
01:21Nursing Assessment of the Genitourinary System I: Health History
01:28Imaging Studies I: Kidney, Ureter, and Bladder Studies
01:19Anatomy of the Genitourinary System II: Bladder and Urethra
01:21Skeletal Muscle Relaxants: Adverse Effects
Unlike...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:26Nursing Assessment of the Genitourinary System II: Inspection and Palpation